检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:卢才义[1] 魏璇[1] 黄丛春[1] 刘朝中[1] 王文清[1] 朴龙松[2] 毛树森[1]
机构地区:[1]空军总医院心内科,北京100036 [2]空军总医院放射科
出 处:《临床心血管病杂志》1999年第12期537-539,共3页Journal of Clinical Cardiology
摘 要:目的:观察经皮激光心肌血运重建术(PMR)治疗晚期冠心病(CHD)的临床疗效。方法:应用PMR治疗10例晚期CHD患者,以Seldinger法经右股动脉将激光导管送入左心室腔内,将激光器调节为2脉冲/串,心电同步于T波易损期前3Oms,在透视指导下对缺血左室壁打孔,深度6mm,每个心室壁打孔9~12个。结果:10例男性CHD患者的年龄为(65.2±5.7)岁,心绞痛级别为(3.4±0.5)级,连用(4.3±1.8)种抗心绞痛药物效果不好,左室壁最大舒张期厚度(11.2±0.9)mm,平均打孔(16.7±3.4)个。随访(6.4±3.7)个月,10例患者的心绞痛级别下降为(2.2±0.3)级(P<0.05),运动耐量由[(327.4±62.8)s增加至(498.6±81.7)s,(P<0.05)],抗心绞痛药物使用种类由[(4.3±1.8)种减少至(3.2±0.4)种,P<0.05],单光子发射计算机体层摄影术心肌显像缺血明显改善,无并发症。结论:PMR治疗晚期严重心绞痛患者是安全有效的,不损害心功能,没有致心律失常作用。但对CHD患者远期疗效和病死率的影响有待进一步观察。objective:To evaluate the effect of percutaneous laser myocardial revascularization(PMR) on the end-stage of ischemic heart disease. Metbod: Ten patients were selected by:①morethan Ⅲ class of angina pectoris;②not suitable for CABG;③without myocardial infarction within 6months;④myocardial ischemia confirmed by ECT or ECG;⑤maximum diastolic wall thickness ofleft ventricle (LV) was≥8mm. PMR was completed via Seldinger technique under the direction ofnuoroscopy. channels were made at the density of l/cm2 left ventricular endocardial surface. Re-sult:Ten patients were male with age of (65. 2 ± 5. 7) years and (3. 4 ± 0. 5) class of angina. Theywere refractory to (4. 3±1. 8) kinds of antiangina druges. The maximum LV diastolic wall thick-ness was (11. 2± 0. 9) mm. CAG showed bivessel or trivessel diffuse lesions. Mean (16. 7± 3. 4)myocardial channels were made. During the follow-up of (6. 4±3.7) months,the angina class de-creased from (3.4 ±0. 5 ) to (2. 2±0. 3 ) (P< 0.05 ). Exercise tolerance was increased from(327.4 ±62. 8) s to (498. 6±81. 7 )s, P<0. 05. The kinds of antiangina drugs were decreasedfrom (4. 3±l. 8) to (3. 2±0. 4) (P<0.05). There were no major complications. Conclusion:It isfeasible and safe of using PMR to treat the end-stage and severe ischemic heart disease. PMR hasno arrhythmogenic effect,dose not impair the heart function. The long-term effect of PMR on rein-farction rate and mortality needs to be further studied.
分 类 号:R541.405[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3